47604-4 |
Cortisol^1.5H post 1 ug/kg CRH IV |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --1.5 hours post 1 ug/kg CRH IV |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
47604-4 |
|
|
|
|
Both |
|
|
|
0 |
Cortis 1.5h p 1 ug/kg CRH IV SerPl-sCnc |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p 1 ug/kg CRH IV; 1.5Hr; 17-Hydroxycorticosterone; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
47605-1 |
Cortisol^15M post 1 ug/kg CRH IV |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --15 minutes post 1 ug/kg CRH IV |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
47605-1 |
|
|
|
|
Both |
|
|
|
0 |
Cortis 15M p 1 ug/kg CRH IV SerPl-sCnc |
|
|
|
N |
|
15M p 1 ug/kg CRH IV; 17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
47606-9 |
Cortisol^1H post 1 ug/kg CRH IV |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --1 hour post 1 ug/kg CRH IV |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
47606-9 |
|
|
|
|
Both |
|
|
|
0 |
Cortis 1h p 1 ug/kg CRH IV SerPl-sCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 17-Hydroxycorticosterone; 1h p 1 ug/kg CRH IV; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
47607-7 |
Cortisol^30M post 1 ug/kg CRH IV |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --30 minutes post 1 ug/kg CRH IV |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
47607-7 |
|
|
|
|
Both |
|
|
|
0 |
Cortis 30M p 1 ug/kg CRH IV SerPl-sCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; 30M p 1 ug/kg CRH IV; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
47608-5 |
Cortisol^pre dose corticotropin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --pre dose corticotropin |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
47608-5 |
|
|
|
|
Both |
|
|
|
0 |
Cortis Pre ACTH SerPl-sCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortrosyn; F; hydrocortisone; Level; Pl; Plasma; Plsm; Point in time; Pre ACTH; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
47609-3 |
Cortisol^pre 1 ug/kg CRH IV |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cortisol [Moles/volume] in Serum or Plasma --pre 1 ug/kg CRH IV |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHAL |
|
47609-3 |
|
|
|
|
Both |
|
|
|
0 |
Cortis pre 1 ug/kg CRH IV SerPl-sCnc |
|
|
|
N |
|
17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; mcg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
4761-3 |
HLA-B53 |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-B53 [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4761-3 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B53 Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
47610-1 |
Creatinine |
SCnc |
Stool |
Pt |
Qn |
|
|
ACTIVE |
Creatinine [Moles/volume] in Stool |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
47610-1 |
|
|
|
|
Both |
|
|
|
0 |
Creat Stl-sCnc |
|
|
|
N |
|
Bowel movement; Chemistry; CR; Crea; Creat; Faecal; Faeces; Fecal; Feces; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47611-9 |
Crystals |
Prid |
Tiss |
Pt |
Nom |
Microscopy.light |
|
ACTIVE |
Crystals [type] in Tissue by Light microscopy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
47611-9 |
|
Microscopy.light |
|
|
Both |
|
|
|
0 |
Crystals Tiss Micro |
|
|
|
N |
|
Crys; Cryst; Crystal; Identity or presence; LM; Micro; Micros; Microscopic; Nominal; Pathology; Point in time; Random; Tissue; Tissue, unspecified |
2.26 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
47612-7 |
Cystatin C |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Cystatin C [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
CHEM |
|
47612-7 |
|
|
|
|
Both |
|
|
|
0 |
Cystatin C Ur-mCnc |
|
|
|
N |
|
Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
47613-5 |
Decanoate/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Decanoate (C10:0)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
47613-5 |
|
|
|
|
Both |
|
|
|
0 |
Decanoate/Creat Ur-sRto |
|
|
|
N |
|
C10:0; Caprate; Capric acid; Chemistry; CR; Crea; Creat; Decanoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.21 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
47614-3 |
Decenoate/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Decenoate (C10:1)/Creatinine [Molar ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
CHEM |
|
47614-3 |
|
|
|
|
Both |
|
|
|
0 |
Decenoate/Creat Ur-sRto |
|
|
|
N |
|
C10:1; Chemistry; CR; Crea; Creat; Decenoic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.21 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
47615-0 |
Dermatan sulfate |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Dermatan sulfate [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
47615-0 |
|
|
|
|
Both |
|
|
|
0 |
Dermatan Sulfate Ur Ql |
|
|
|
N |
|
Chemistry; Chondroitin B sulfate; Dermatin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SO4; SO4-2; Sulf; UA; UR; Urn |
2.56 |
2.21 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
47616-8 |
Estradiol^1H post dose corticotropin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Estradiol (E2) [Mass/volume] in Serum or Plasma --1 hour post dose corticotropin |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
47616-8 |
|
|
|
|
Observation |
|
|
|
0 |
Estradiol 1h p ACTH SerPl-mCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 17-beta estradiol; 1h p ACTH; 60 min; 60 minutes; 60M; 60min; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; E2; Level; Mass concentration; Oestradiol; p ACTH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker |
2.7 |
2.21 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
47617-6 |
Estradiol^pre dose corticotropin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Estradiol (E2) [Mass/volume] in Serum or Plasma --pre dose corticotropin |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
47617-6 |
|
|
|
|
Observation |
|
|
|
0 |
Estradiol Pre ACTH SerPl-mCnc |
|
|
|
N |
|
17-beta estradiol; ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Before; c206; c74; CHEMISTRY.CHALLENGE TESTING; Cortrosyn; E2; Level; Mass concentration; Oestradiol; Pl; Plasma; Plsm; Point in time; Pre ACTH; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker |
2.7 |
2.21 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
47618-4 |
Follitropin^15M post 100 ug luteinizing releasing hormone IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Follitropin [Units/volume] in Serum or Plasma --15 minutes post 100 ug luteinizing releasing hormone IV |
|
MIN |
DefinitionDescription |
|
|
IU/L;mIU/mL |
|
|
|
|
|
|
CHAL |
|
47618-4 |
|
|
|
|
Both |
|
|
|
0 |
FSH 15M p 100 ug LRH IV SerPl-aCnc |
|
|
|
N |
|
15M p 100 ug LRH IV; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; Horm; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
Release 2.69: COMPONENT: Corrected "lutenizing" to "luteinizing"; |
0 |
47619-2 |
Follitropin^2.5H post 100 ug luteinizing releasing hormone IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Follitropin [Units/volume] in Serum or Plasma --2.5 hours post 100 ug luteinizing releasing hormone IV |
|
MIN |
DefinitionDescription |
|
|
IU/L;mIU/mL |
|
|
|
|
|
|
CHAL |
|
47619-2 |
|
|
|
|
Observation |
|
|
|
0 |
FSH 2.5h p 100 ug LRH IV SerPl-aCnc |
|
|
|
N |
|
2.5h p 100 ug LRH IV; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; Horm; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.21 |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
Release 2.69: COMPONENT: Corrected "lutenizing" to "luteinizing"; |
0 |
4762-1 |
HLA-B54(22) |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-B54(22) [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4762-1 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-B54(22) Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
47620-0 |
Glucose |
SCnc |
Stool |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Stool |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
47620-0 |
|
|
|
|
Both |
|
|
|
0 |
Glucose Stl-sCnc |
|
|
|
N |
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Glu; Gluc; Glucoseur; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Concentration |
2.7 |
2.21 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
47621-8 |
Glucose.IV |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Glucose.IV [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
47621-8 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose IV Dose |
|
|
|
N |
|
Dose med or substance; DRUG DOSES; Glu; Gluc; Glucose IV; Glucoseur; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.69 |
2.21 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
47622-6 |
Glucose^pre dose glucose |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --pre dose glucose |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
47622-6 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose pre Glc SerPl-sCnc |
|
|
|
N |
|
Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Pl; Plasma; Plsm; Point in time; pre Glc; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
2.21 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
47623-4 |
Glutamate |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Glutamate [Moles/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
47623-4 |
|
|
|
|
Both |
|
|
|
0 |
Glutamate DBS-sCnc |
|
|
|
N |
|
Blood; c707; Chemistry; DBS; Dried blood spot; Filter paper; FP; Glu; Glutamic acid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.7 |
2.21 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47624-2 |
Glutamate/Amino acids.total |
SFr |
Hair |
Pt |
Qn |
|
|
ACTIVE |
Glutamate/Amino acids.total in Hair |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
47624-2 |
|
|
|
|
Both |
|
|
|
0 |
Glutamate SFr Hair |
|
|
|
N |
|
AA; Acd; Acid; Amino acid; Amino acids.total; c707; Chemistry; Glu; Glutamic acid; Har; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance fraction; Tot; Totl |
2.7 |
2.21 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
47625-9 |
Glutamate/Amino acids.total |
SFr |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Glutamate/Amino acids.total in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
47625-9 |
|
|
|
|
Both |
|
|
|
0 |
Glutamate SFr CSF |
|
|
|
N |
|
AA; Acd; Acid; Amino acid; Amino acids.total; c707; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Glu; Glutamic acid; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance fraction; Tot; Totl |
2.7 |
2.21 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
47626-7 |
Glutamate/Amino acids.total |
SFr |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Glutamate/Amino acids.total in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
47626-7 |
|
|
|
|
Both |
|
|
|
0 |
Glutamate SFr Amn |
|
|
|
N |
|
AA; Acd; Acid; AF; Amino acid; Amino acids.total; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; c707; Chemistry; Glu; Glutamic acid; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance fraction; Tot; Totl |
2.7 |
2.21 |
|
|
|
|
|
|
|
% |
|
|
|
0 |